bpc 157 and thymosin beta 4 benefits BPC-157 / Beta-4 TB-500 Benefits and Research Applications

Ethical Approval This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors

The convenient oral administration eliminates injection requirements while maintaining exceptional bioavailability and therapeutic efficacy

Researchers initially identified BPC-157 while analyzing human gastric secretions

Maintenance then reduces to 2mg once every 7-14 days

This keeps the math identical to every other vial size using the base-10 approach, where each 10 units equals 1mg

Please request a consultation using the online form or call us at (225) 960-1580 to schedule an appointment